Amneal Pharmaceuticals, Inc. vs. Nivagen Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2025-00779 filed by Amneal Pharmaceuticals, Inc. on 2025-04-11. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-00779

Filing Date

2025-04-11

Accorded Filing Date

2025-04-11

Institution Decision Date

2025-09-03

Last Modified Date

2025-10-04

Proceeding Type

IPR

Termination Date

2025-09-03

Trial Status

Discretionary Denial

Parties & Counsel

Petitioner

Amneal Pharmaceuticals, Inc.

Represented By

Briggs, Heathet al

Patent Owner / Respondent

Nivagen Pharmaceuticals, Inc.

Represented By

Upadhye, Shashanket al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17499001

Respondent Patent Number 11813291

External Links

Espacenet

Google Patents

Respondent Inventor Brijeshkumar B. Pandya et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

6 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Umberg Zipser LLP

Customer Number 149344

Address 1920 Main Street Suite 750, Irvine, CA, 92614, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
46697	Martin Fessenmaier	949-679-0052
56122	Mei Tsang	949-679-0052
61570	Ryan Dean	949-679-0052
70109	Priti Phukan	949-679-0052
81519	Darian Mcmillan	858-922-4780
83775	Nasser Khateeb	949-679-0052

Proceeding Documents

Director Discretionary Decision: Deny RESPONSE

2025-09-03 FILING PARTY: BOARD

Download

20250825 Patent Owner Nivagen Updated Mandatory Notice 291 pat IPR 00779 NOTICE

2025-08-25 FILING PARTY: PATENT OWNER

Download

20250825 Patent Owner Nivagen Updated Power of Atty '291 IPR00779 (executed) NOTICE

2025-08-25 FILING PARTY: PATENT OWNER

Download

Order: ORDER Granting Patent Owner’s Motion for Admission Pro Hac Vice of Yixin H. Tang 37 C.F.R. § 42.10 ORDER

2025-08-20 FILING PARTY: BOARD

Download

Petitioner's Opposition to Patent Owner's Brief in Support of Discretionary Denial RESPONSE

2025-08-20 FILING PARTY: PETITIONER

Download

Amneal Pharmaceuticals, Inc. vs. Nivagen Pharmaceuticals, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Amneal Pharmaceuticals, Inc.

Represented By

Patent Owner / Respondent

Nivagen Pharmaceuticals, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Director Discretionary Decision: Deny RESPONSE

20250825 Patent Owner Nivagen Updated Mandatory Notice 291 pat IPR 00779 NOTICE

20250825 Patent Owner Nivagen Updated Power of Atty '291 IPR00779 (executed) NOTICE

Order: ORDER Granting Patent Owner’s Motion for Admission Pro Hac Vice of Yixin H. Tang 37 C.F.R. § 42.10 ORDER

Petitioner's Opposition to Patent Owner's Brief in Support of Discretionary Denial RESPONSE

Ex1038-JudgeWilliams-Stats Exhibit

Ex1040-SchedulingOrder-1_22-cv-01190-GBW_280 Exhibit

Ex1041-SchedulingOrder-1_25-cv-00338-GBW_16 Exhibit

Ex1042-SchedulingOrder-1_23-cv-01095-GBW_36 Exhibit

ORDER Conditionally Granting Patent Owner’s Motion for Admission Pro Hac Vice of Christopher M. Bruno 37 C.F.R. § 42.10 ORDER

Ex1039-SchedulingOrder-1_22-cv-00266-JDW_133 Exhibit

Ex2031-NorwoodCV Exhibit

20250819-Nivagen's Pat Own Prelim Resp '291patent IPR2025-00779 POPR

Ex2030-NorwoodDecl Exhibit

20250819 Patent Owner Nivagen Motion for C. Bruno PHV '291 pat IPR 00779 MOTION

Ex2029-VanDerLinden Exhibit

Ex2018-DI42-Reply-PI Exhibit

Ex2017-DI36-OppoBr-PI Exhibit

Ex2010-Franzetti-2009 Exhibit

Ex2011-Graves-2011 Exhibit

Ex2014-JtComm-2013 Exhibit

Ex2012-Lutwick2019 Exhibit

Ex2005-Compare-Thomas-Ex1007 Exhibit

Patent Owner's Brief In Support of Discretionary Denial RESPONSE

Ex2023-DI102-Reply-MTD Exhibit

Ex2009-Rosenthal-2004 Exhibit

Ex2022-DI101-OppBr-MTD Exhibit

Ex2024-Email-Sotera Exhibit

Ex2007-RabinowCV Exhibit

Ex2013-US11141430-Koneru Exhibit

Ex2008-Rangel-Frausto-2010 Exhibit

Ex2015-Nivagen-v-Amneal-DDel-Docket Exhibit

Ex2020-DI93-Defs Answer and Counterclaims Exhibit

Ex2004-Examiner-ReportAL-AWADI Exhibit

Ex2002-SakowskiDecl Exhibit

Ex2021-DI95-Nivagen Brief in Support Mot to Dismiss Exhibit

Ex2026-DI29-AmijiDec Exhibit

Ex2016-DI22-OpenBr Exhibit

Ex2001-US10632150-Thomas Exhibit

Ex2003-CA-24-846-DI-61-Opinion Exhibit

Ex2006-Rabinow-Decl-291 Exhibit

Motion Pro Hac Vice - Yixin Tang MOTION

Notice: Mandatory Notice NOTICE

Notice: Power of Attorney NOTICE

Notice: Notice filing date accorded NOTICE

ISMP Canada Safety Bulletin, Volume 6, Issue 2 April 25, 2006 Exhibit

International Patent Application Publication No. WO2020/081118 Exhibit

Litigation Docket and Statistics for Judge Williams, D. Del. Exhibit

Orange Book, September 2019 Exhibit

Brunelli Exhibit

Ogawa Exhibit

Dailymed CMP FDA Drug Label September 23, 2020, Internet Archive Exhibit

Terlevich Exhibit

Declaration of Dr. Sylvia Hall-Ellis, Ph.D. Exhibit

Petition: as filed PETITION

Declaration of Dr. Mansoor Amiji Exhibit

Perks Exhibit

U.S. Patent No. 4,872,553 Exhibit

Rowe Exhibit

Curriculum Vitae of Dr. Mansoor M. Amiji Exhibit

Ex Parte Shirley Exhibit

U.S. Patent No. 6,713,137 Exhibit

U.S. Patent No. 6,007,529 Exhibit

US11813291 Exhibit

TechnoFlex Website: “PP bags for ready-to-use solution” Exhibit